[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368044-105":59,"doc-detail-368044-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","small-extracellular-vesicles-unraveling-their-roles-in-ovarian-cancer-progression-and-tapping-into-clinical-application-potential","Small Extracellular Vesicles: Unraveling Their Roles in Ovarian Cancer Progression and Tapping Into Clinical Application Potential","","Ovarian cancer is an aggressive gynecologic malignancy with high mortality, early sensitivity to platinum therapy, and frequent recurrence after surgery and chemotherapy. Small extracellular vesicles (sEVs) are 40–160 nm “cup-shaped” nanovesicles that transport nucleic acids, oncogenic proteins, lipids, and metabolites, enabling intercellular communication and promoting tumor progression. This review integrates sEV functions from multiple cell sources, covering proliferation, metastasis, drug resistance, angiogenesis, immune escape, and stemness.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/small-extracellular-vesicles-unraveling-their-roles-in-ovarian-cancer-progression-and-tapping-into-clinical-application-potential/368044/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/small-extracellular-vesicles-unraveling-their-roles-in-ovarian-cancer-progression-and-tapping-into-clinical-application-potential/368044.png","ImageObject",300,407,{"name":92,"@type":93},"hdkawk","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What roles do small extracellular vesicles (sEVs) play in ovarian cancer progression?","Question",{"text":112,"@type":113},"sEVs promote progression by delivering molecular cargos to target cells or organs. The review highlights effects on proliferation, metastasis, drug resistance, angiogenesis, immune escape, and stemness.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How can sEVs contribute to clinical diagnosis and prognosis of ovarian cancer?",{"text":117,"@type":113},"sEVs are explored as biomarker candidates for diagnosis and prognosis. Their biological cargo and communication functions support their potential clinical value.",{"name":119,"@type":110,"acceptedAnswer":120},"Why is immune checkpoint inhibitor therapy still limited in ovarian cancer?",{"text":121,"@type":113},"The review notes that ICI-based therapy shows only a 10–15% therapeutic response rate and remains constrained by issues such as inflammatory toxicities.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368044,1791542779,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},3985747859855,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","International Journal of Nanomedicine  \nOpen Access Full Text Article REVIEW  \nSmall Extracellular Vesicles: Unraveling Their Roles in Ovarian Cancer Progression and Tapping Into Clinical Application Potential  \nYuan Zhou 1 , Danni Ding2 , Fangyuan Liu2 , Fengjuan Han 2  \n1Department of Obstetrics and Gynecology, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, 150040, People’s Republic of China; 2Department of Obstetrics and Gynecology, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, 150040, People’s Republic of China  \nCorrespondence: Fengjuan Han, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, 150040, People’s Republic of China, Email [hanfengjuan2004@163.com](hanfengjuan2004@163.com)  \n\n| Abstract: Among gynecologic malignancies, ovarian cancer (OC) stands out as a highly aggressive disease with the highest mortality rate and the poorest prognosis. At the beginning stage, it demonstrates high sensitivity to platinum-based chemotherapy. Nevertheless, most patients will encounter recurrence following the initial surgery and chemotherapy. Small extracellular vesicles (sEVs), characterized by a “cup-shaped” morphology and with a diameter of 40 to 160 nm, encompass diverse biologically active substances including nucleic acids (such as DNA, mRNA, microRNA (miRNA), and other non-coding RNAs (ncRNAs)), as well as oncogenic proteins, lipids, and metabolites, which play a crucial role as mediators of intercellular communication. Increasing evidence shows that sEVs promote various cancers’ progression (including OC) via transporting molecular cargoes to target cells or organs. It is worth mentioning that existing literature often focuses on sEVs from a single cell type and lacks a comprehensive review of multiple cell sources. In this review, we summarize the biological functions of sEVs derived from different cell types in OC, including regulating cell proliferation, promoting metastasis, mediating drug resistance, inducing angiogenesis, facilitating immune escape, and maintaining stemness. Meanwhile, we focus on exploring the clinical value of sEVs as biomarkers for the diagnosis and prognosis of OC, as well as their application potential in translational medicine fields related to cancer vaccine development, targeted drug delivery, and precision tumor-targeted therapy. Additionally, we analyze the major challenges currently faced in sEV-based OC treatment research and propose potential strategies to overcome these limitations.\u003Cbr>Keywords: small extracellular vesicles, ovarian cancer, biological functions, biomarker, therapeutic research |\n| --- |\n| Introduction\u003Cbr>Ovarian cancer (OC) ranks third in terms of commonality and is the most lethal malignant tumor within the female reproductive system. Globally, 313,959 cases of OC occur annually, while more than 150,000 deaths from OC occur annually.1–4 Numerous challenges exist in the early diagnosis of OC. Owing to the absence of specific early symptoms and effective screening approaches, 70% of patients are diagnosed at advanced stages (FIGO stage III or IV) when distant metastases have already occurred.5 The typical treatment protocol for OC (integrating tumor cytoreduction and platinum-based chemotherapy) proves effective merely in a limited number of patients. The majority of patients experience relapse after undergoing initial surgery and chemotherapy, and the overall 5-year survival rate is 49.7% .6 Notably, the application of anti-programmed death 1 (PD-1)/programmed death-ligand 1 (PD-L1) immune checkpoint inhibitors (ICIs) has exerted a transformative impact on the treatment paradigm of OC to a certain extent.7 Regrettably, however, regardless of whether they are utilized as a monotherapy or in a combination regimen, their efficacy in the treatment of OC has never managed to meet the expected level.8 Relevant cli","cbCairWqfpughSRL","https://ap.wps.com/l/cbCairWqfpughSRL","pdf",4208273,29,"English","# Introduction\n## Ovarian cancer burden and current treatment challenges\n## sEV characteristics and cargo-mediated communication\n# Clinical application potential of sEVs\n## sEVs as biomarkers for diagnosis and prognosis\n## Translational applications in cancer therapy\n# Challenges and strategies in sEV-based research","[{\"question\":\"What roles do small extracellular vesicles (sEVs) play in ovarian cancer progression?\",\"answer\":\"sEVs promote progression by delivering molecular cargos to target cells or organs. The review highlights effects on proliferation, metastasis, drug resistance, angiogenesis, immune escape, and stemness.\"},{\"question\":\"How can sEVs contribute to clinical diagnosis and prognosis of ovarian cancer?\",\"answer\":\"sEVs are explored as biomarker candidates for diagnosis and prognosis. Their biological cargo and communication functions support their potential clinical value.\"},{\"question\":\"Why is immune checkpoint inhibitor therapy still limited in ovarian cancer?\",\"answer\":\"The review notes that ICI-based therapy shows only a 10–15% therapeutic response rate and remains constrained by issues such as inflammatory toxicities.\"}]","Small Extracellular Vesicles: Unraveling Their Roles in Ovarian Cancer Progression and Tapping Into Clinical Application Potential | PDF",1790174611,73,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/47e033cf6eb5aaabeed0a2447c88d80b.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/29dd93c106ef22c4f61fe9c496d1a2b6.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cbcba5a37335554417a2f7828a37b82e.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/19e1c2849591ac61e899e95e372275f3.webp",980,1268]